Clinical Trial: Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898566) titled 'Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia' on Oct. 20.

Brief Summary: This study evaluated the efficacy and safety of two concentrations of CosmeRNA-ARI Anti Hair Loss Tonic in adults with androgenetic alopecia. Participants were randomly assigned to receive the low-concentration investigational product, the high-concentration investigational product, or a vehicle control product without the active ingredient. Each assigned product was applied to the scalp once every 2 weeks for 24 weeks. Hair density, hair thickness, hair growth rate, expert-assessed changes in hair density, parti...